Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$2.61 - $4.42 $219 - $371
-84 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$5.03 - $6.31 $422 - $530
84 New
84 $0
Q4 2019

Jan 31, 2020

SELL
$6.48 - $8.76 $1,736 - $2,347
-268 Closed
0 $0
Q1 2019

Apr 26, 2019

SELL
$6.82 - $10.27 $2,264 - $3,409
-332 Reduced 55.33%
268 $2,000
Q4 2018

Feb 05, 2019

BUY
$7.65 - $12.83 $4,590 - $7,698
600 New
600 $5,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.